Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the United States, announced the publication of new research in PLOS Pathogens identifying a novel mechanism that may trigger ...

Following the drive to understand and control bacteria, it’s becoming clear that our methods have changed the very organisms we aim to understand, increasing resistance to tried-and-true antimicrobial ...

Symptoms that persist long after Lyme disease is treated are not uncommon - a 2022 study found that 14% of patients who were diagnosed and treated early with antibiotic therapy would still develop ...

A first look into the molecular defenses of archaea highlights the importance of surveying diverse microbes to discover new types of antimicrobials As bacteria become increasingly resistant to ...